BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Liquidia begins testing flu vaccine
News | 10. 06. 2010
Liquidia Technologies
Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
